Testing of the preliminary OMERACT validation criteria for a biomarker to be regarded as reflecting structural damage endpoints in rheumatoid arthritis clinical trials: the example of C-reactive protein

Stephanie O Keeling, Robert Landewe, Desiree van der Heijde, Joan Bathon, Maarten Boers, Patrick Garnero, Piet Geusens, Hani El-Gabalawy, Robert D Inman, Virginia B Kraus, Tore K Kvien, Philip J Mease, Mikkel Ostergaard, Chris Ritchlin, Silje W Syversen, Walter P Maksymowych

    16 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Testing of the preliminary OMERACT validation criteria for a biomarker to be regarded as reflecting structural damage endpoints in rheumatoid arthritis clinical trials: the example of C-reactive protein'. Together they form a unique fingerprint.

    Medicine & Life Sciences